TLRY Tilray

Tilray Brands to Announce Fourth Quarter and Fiscal Year 2025 Financial Results on July 28, 2025

Tilray Brands to Announce Fourth Quarter and Fiscal Year 2025 Financial Results on July 28, 2025

NEW YORK and LEAMINGTON, Ontario, July 09, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the beverage, cannabis and wellness industries, today announced that the Company will release its financial results for the fourth quarter and full fiscal year ended May 31, 2025, after market close on Monday, July 28, 2025.

Live Conference Call and Audio Webcast

Tilray will host a live conference call, which will be webcast, to discuss these results at 4:30 PM Eastern Time. The webcast can be accessed on the section of Tilray’s Investor Relations website.

About Tilray Brands

Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), is a leading global lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America that is leading as a transformative force at the nexus of cannabis, beverage, wellness, and entertainment, elevating lives through moments of connection. Tilray’s mission is to be a leading premium lifestyle company with a house of brands and innovative products that inspire joy, wellness and create memorable experiences. Tilray’s unprecedented platform supports over 40 brands in over 20 countries, including comprehensive cannabis offerings, hemp-based foods, and craft beverages.

For more information on how we are elevating lives through moments of connection, visit Tilray.com and follow @Tilray on all social platforms.

Contacts:

Investor Relations



Media



EN
09/07/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Tilray

 PRESS RELEASE

Tilray Brands to Announce Fourth Quarter and Fiscal Year 2025 Financia...

Tilray Brands to Announce Fourth Quarter and Fiscal Year 2025 Financial Results on July 28, 2025 NEW YORK and LEAMINGTON, Ontario, July 09, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the beverage, cannabis and wellness industries, today announced that the Company will release its financial results for the fourth quarter and full fiscal year ended May 31, 2025, after market close on Monday, July 28, 2025. Live Conference Call and Audio Webcast Tilray will ho...

 PRESS RELEASE

Beers, Live Music, Hot Dogs and Fireworks: Everything You Need for an ...

Beers, Live Music, Hot Dogs and Fireworks: Everything You Need for an Epic 4th Of July Celebration Tilray Brands Announces Independence Day Parties Across the U.S. NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company, is excited to share that its craft beer taprooms across the U.S. are rolling out a stellar lineup of events to make this 4th of July unforgettable. From live music and limited-release brews to barbecues and Independence Day festivities, each taproom is set to bring its o...

 PRESS RELEASE

Breckenridge Distillery Unveils Limited-Edition Collectors Art Series ...

Breckenridge Distillery Unveils Limited-Edition Collectors Art Series Collaboration with Renowned Artist Miles Toland For Its Fifth Annual Collectors Art Series, Breckenridge Distillery Partners with Visionary Artist to Create Label for Its New Calvados Cask Release BRECKENRIDGE, Colo., July 01, 2025 (GLOBE NEWSWIRE) -- , one of the most-awarded craft distilleries in the U.S., and a craft spirits brand by Tilray Brands, Inc. (NASDAQ: TLRY and TSX: TLRY), proudly announces the fifth edition of its acclaimed . This year, the distillery partnered with muralist and painter Miles Toland to c...

 PRESS RELEASE

Tilray Medical veröffentlicht bahnbrechende Forschungsergebnisse zur P...

Tilray Medical veröffentlicht bahnbrechende Forschungsergebnisse zur Pharmakokinetik von THC- und CBD-Formulierungen Neue Studie liefert Erkenntnisse über die Bioverfügbarkeit von medizinischen Cannabisformulierungen für therapeutische Behandlungen NEW YORK, June 27, 2025 (GLOBE NEWSWIRE) -- Tilray Medical, ein Geschäftsbereich von Tilray Brands, Inc. („Tilray” oder das „Unternehmen”) (Nasdaq: TLRY; TSX: TLRY) und ein weltweit führender Anbieter von medizinischem Cannabis, der die therapeutische Allianz zwischen Patienten und Ärzten stärkt, um fundierte, individuelle Gesundheitsentschei...

 PRESS RELEASE

Tilray Medical publie une recherche pionnière sur la pharmacocinétique...

Tilray Medical publie une recherche pionnière sur la pharmacocinétique des formulations de THC et de CBD La nouvelle étude fournit des informations sur la biodisponibilité des formulations de cannabis thérapeutique à des fins thérapeutiques NEW YORK, 27 juin 2025 (GLOBE NEWSWIRE) -- Tilray Medical, une division de Tilray Brands, Inc. (« Tilray » ou la « Société ») (Nasdaq : TLRY ; TSX : TLRY) et leader mondial du cannabis thérapeutique, qui favorise l’alliance thérapeutique entre les patients et les professionnels de santé afin de leur permettre de prendre des décisions éclairées et per...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch